n-(4-(4-maleimidophenyl)butyryl)phosphatidylethanolamine has been researched along with Brain Diseases in 1 studies
*Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cózar-Bernal, MJ; García-Esteban, E; González-Rodríguez, ML; Rabasco, AM; Sánchez-Soto, PJ | 1 |
1 other study(ies) available for n-(4-(4-maleimidophenyl)butyryl)phosphatidylethanolamine and Brain Diseases
| Article | Year |
|---|---|
Surface functionalizing of a lipid nanosystem to promote brain targeting: step-by-step design and physico-chemical characterization.
Topics: Brain; Brain Diseases; Chemistry, Pharmaceutical; Drug Delivery Systems; Immunoglobulin G; Lipids; Liposomes; Nanoparticles; Particle Size; Phosphatidylethanolamines | 2016 |